Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Controlled Study of Postoperative Adjuvant Therapy Using TS-1 or TS-1+PSK for Stage II or III Gastric Cancer Patients

NCT00687843 is registered in ClinicalTrials.gov with Tokyo Metropolitan Oncology Group as lead sponsor.

NCT NCT00687843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00687843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Controlled Study of Postoperative Adjuvant Therapy Using TS-1 or TS-1+PSK for Stage II or III Gastric Cancer Patients
Lead sponsor
Tokyo Metropolitan Oncology Group
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2008
Completion date
March 31, 2016
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer